Cognito Therapeutics

About:

Cognito Therapeutics is a neurotechnology company that is developing disease-modifying treatments for CNS illnesses.

Website: https://www.cognitotx.com

Twitter/X: cognitotx

Top Investors: IAG Capital Partners, FoundersX Ventures, Morningside Venture Investments, Alzheimer's Drug Discovery Foundation, Starbloom Capital

Description:

Cognito Therapeutics is a clinical-stage neurotechnology business focused on creating disease-modifying pharmaceutical methods for the treatment of neurodegenerative illnesses. Li-Huei Tsai and Ed Boyden, MIT Professors, and scientific founders, created its non-invasive neuromodulation platform. The Company's primary therapy is now being studied in a pivotal study for Alzheimer's Disease and has been designated as a Breakthrough Device by the FDA.